[Renhaim Inc./(주)레나임] 유전자·세포치료제 및 사업개발(BD)담당 등 경력직 채용

  • May 23, 2024 5:06 AM
    Message # 13360668

    ▶ About us

    Renhaim Inc., co-founded by EyeGene Inc. and BMI Korea, has a strategic partnership with PeproMene Bio Inc. in the U.S. Renhaim has in-licensed a novel target CAR-T therapy with an exclusive domestic right from PeproMene Bio. Renhaim is looking to recruit a cell therapy expert for further synergies with the strategic partner.

    1. Position

    • R&D Head of RNA-based therapeutics (Gene Therapy)
    • R&D Head of Cell Therapies
    • Business Development 

    2. Responsibility : Please refer to the attached file.

    3. Recruitment procedures : Document Screening → 1st interview → 2nd interview → Join us

    Please send your CV or Resume to manager via email(ywlee@renhaim.com) to apply.

    Please Visit our website (www.renhaim.com) to learn more about who we are and what we do. Thank You. 

    1 file
Powered by Wild Apricot Membership Software